---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-035515"
form_type: "8-K"
ticker: "ULBI"
cik: "0000875657"
company_name: "ULTRALIFE CORP"
filed_at: "2025-11-18T23:59:59+00:00"
generated_at: "2026-05-16T18:59:47.540574+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Ultralife Q3 sales up 21.5% to $43.4M; GAAP loss per share of $0.07 on Calgary closure charge

## Summary
- Sales $43.4M (+21.5% YoY, including Electrochem); organic growth 2.5%. Backlog $90.1M vs $84.5M at Q2 2025.
- GAAP EPS ($0.07) vs $0.02; operating loss $1.0M includes $1.1M non-recurring costs (Calgary facility closure).
- Gross margin 22.2% down from 24.3% on raw material quality issues; adjusted EBITDA $2.0M vs $1.9M.
- Battery & Energy Products sales +22.8% (ex-Electrochem +1.9%); government/defense sales +19.0%.
- Calgary closure charge $0.5M; expected annual savings ~$0.8M after completion in Q1 2026.

## SEC filing metadata
- accession: 0001437749-25-035515
- form_type: 8-K
- ticker: ULBI
- cik: 0000875657
- company_name: ULTRALIFE CORP
- filed_at: 2025-11-18T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/875657/000143774925035515/0001437749-25-035515-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/875657/000143774925035515/ulbi20251117_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-035515
- JSON: https://secwatch.observer/filing/0001437749-25-035515.json
- Plain text: https://secwatch.observer/filing/0001437749-25-035515.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.